Toremifene citrate (Acapodene) trial interim results
The men’s health company GTx has announced two sets of of interim results in the past month from its pivotal Phase III clinical trial of Acapodene (toremifene citrate) for the treatment of side effects of androgen deprivation therapy (ADT) for prostate cancer.
(full story…)